Table 2.
Odds of ROC-line call among combined analytic sample (n = 29,214)
Factor | OR | SE | 95% CI | p value |
---|---|---|---|---|
At Risk (ref = no) | ||||
Yes | 1.18 | 0.05 | 1.07 to 1.30 | < 0.001 |
Race/Ethnicity (ref = white) | ||||
Black | 2.77 | 0.07 | 2.40 to 3.21 | < 0.001 |
Hispanic/latino | 1.28 | 0.09 | 1.08 to 1.53 | 0.005 |
Other/unknown | 1.83 | 0.11 | 1.47 to 2.26 | < 0.001 |
Insurance (ref = private) | ||||
Medicaid | 1.65 | 0.07 | 1.45 to 1.88 | < 0.001 |
Medicare | 1.82 | 0.08 | 1.56 to 2.12 | < 0.001 |
Uninsured | 2.19 | 0.07 | 1.89 to 2.53 | < 0.001 |
Gender (ref = female) | ||||
Male | 1.01 | 0.05 | 0.92 to 1.11 | 0.839 |
PHPA residency (ref = non-PHPA) | ||||
PHPA | 1.57 | 0.05 | 1.43 to 1.72 | < 0.001 |
ROC line call defined as having at least 1 call at any time during the campaign April 21, 2020–May 12, 2020. Analytic Sample represents a subset of the campaign population defined as those meeting the exclusion criteria including those without Healthcare System contact (ROC call, health care appointment, or COVID-19 test) prior to the start of the campaign. At Risk defined as patients one or more moderate comorbidities for COVID-19 including elderly (65 years-old or more) or adults (18 years-old or more) with one or more of the following comorbidities: severe obesity, diabetes, chronic obstructive pulmonary disease /emphysema, asthma, hypertension, coronary artery disease, congestive heart failure, lupus, sarcoidosis, immunodeficiency; and excluding: patients currently on dialysis, had a history of a left ventricular assist device procedure, were active or recent transplant patients, or have malignancy, HIV/AIDs, or sickle cell disease
ROC regional operation call center; OR odds ratio; SE standard error; CI confidence interval; PHPA public health priority areas selected by the county health department as areas with disproportionately low educational attainment and high poverty